Last reviewed · How we verify
NCT06632691: VIRTU
Virtual Reality Headset and Acceptability of Rectosigmoidoscopy in Ulcerative Colitis: a Randomised Controlled Trial
NA trial testing Virtual reality headset in Haemorrhagic Rectocolitis in 100 participants. Currently enrolling.
9 April 2027
Quick facts
| Lead sponsor | Centre Hospitalier Departemental Vendee |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 9 October 2024 |
| Primary completion | 9 April 2027 |
| Estimated completion | 9 April 2027 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Virtual reality headset
Conditions studied
- Haemorrhagic Rectocolitis — all drugs for Haemorrhagic Rectocolitis →
Sponsor
Centre Hospitalier Departemental Vendee
Who can join
18 and older, any sex, with Haemorrhagic Rectocolitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Haemorrhagic rectocolitis is an inflammatory bowel disease that continuously affects the rectum and colon, with lesions that extend variably from the rectum into the upstream colon. This disease requires repeated assessment of both clinical activity (transcribed by the clinical Mayo score) and endoscopic activity. ACCEPT study showed that the acceptability of rectosigmoidoscopy is low, and the main determinants of this low acceptability were pain and bloating (51%) and embarrassment during the examination (30%). Virtual reality headsets has analgesic and anxiolytic properties, thanks to specially designed virtual environments that apply different principles such as medical hypnosis, music therapy and cardiac coherence to enhance therapeutic action. The aim of our project is to study the benefit of medical hypnosis provided by the use of a virtual reality headset in terms of tolerance of lower digestive endoscopy in patients with ulcerative colitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06632691
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual reality headset
Trials testing the same drug.
- NCT07452341 — Effect of Virtual Reality on Depression in Adolescent Females · NA · not yet recruiting
- NCT06745765 — Virtual Reality for Anxiety in Interventional Radiology Procedures · NA · recruiting
- NCT06522711 — Virtual Reality for Anxiolysis and Pharmacological Sparing · NA · not yet recruiting
- NCT07013695 — Evaluation of the Impact of Virtual Reality on Sedation Use in Patients Undergoing Regional Anesthesia for Scheduled Ort · NA · recruiting
- NCT07250282 — Impact of Virtual Reality on Anxiety and Pain During Implantation of Cardiac Implantable Electronic Devices (CIED) · NA · completed
Other Centre Hospitalier Departemental Vendee trials
Trials by the same sponsor.
- NCT07489820 — Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation · NA · not yet recruiting
- NCT07313293 — Impact of Foot Reflexology on Nausea After Obesity Surgery · NA · recruiting
- NCT07314632 — Prospective Study in Laser Treatment of Pilonidal Cysts · recruiting
- NCT07340060 — Statistical Association Between Bicarbonate Levels and Death or Admission to Intensive Care Within 48 Hours in Patients · recruiting
- NCT07228767 — Assessment of Surgeons' Mental Fatigue Based on Operating Time · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06632691 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Departemental Vendee
- Last refreshed: 1 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06632691.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing